Rezultati

eNauka >  Results >  Real-World Outcomes of First-Line Pembrolizumab Monotherapy in Metastatic NSCLC with High PD-L1 Expression (TPS ≥ 50%): A Multicenter Study from Serbia
Title: Real-World Outcomes of First-Line Pembrolizumab Monotherapy in Metastatic NSCLC with High PD-L1 Expression (TPS ≥ 50%): A Multicenter Study from Serbia
Authors: Marković, Filip; Stjepanović, Mihailo  ; Rančić, Milan  ; Cekić, Marina; Kontić, Milica  
Issue Date: 2025
Publication: Biomedicines
ISSN: 2227-9059 Biomedicines Search Idenfier
Publisher: Basel, Switzerland : MDPI AG
Type: Article
Collation: vol. 13 br. 5 str. 1175
DOI: 10.3390/biomedicines13051175
WoS-ID: 001497799100001
Scopus-ID: 2-s2.0-105006737175
PMID: 40427002
PMCID: PMC12108898
URI: https://enauka.gov.rs/handle/123456789/984076
URL: https://www.mdpi.com/2227-9059/13/5/1175
Project: Ministry of Education, Science and Technological Development of the Republic of Serbia
[200110]
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

5
SCOPUSTM
2
PubMed CentralTM
3
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.